Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Dow
AstraZeneca
McKinsey
Cipla
Boehringer Ingelheim
Johnson and Johnson
Deloitte
Julphar

Generated: February 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,910,214

« Back to Dashboard

Summary for Patent: 4,910,214
Title: Optical isomer of an imidazole derivative medetomidine as an alpha-2-receptor agonist
Abstract:The separated d and l enantiomers of medetomidine and their salts are selective and potent .alpha..sub.2 -receptor agonists.
Inventor(s): Karjalainen; Arto J. (Oulu, FI), Virtanen; Raimo E. (Rusko, FI), Savolainen; Eino J. (Oulu, FI)
Assignee: Farmos Yhtyma Oy (Turku, FI)
Application Number:07/219,637
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 4,910,214

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,910,214

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8716803Jul 16, 1987

International Patents Family Members for US Patent 4,910,214

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 71941 ➤ Sign Up
Australia 1894188 ➤ Sign Up
Australia 600839 ➤ Sign Up
Bulgaria 60473 ➤ Sign Up
Canada 1337659 ➤ Sign Up
China 1022323 ➤ Sign Up
China 1030576 ➤ Sign Up
Cyprus 1787 ➤ Sign Up
German Democratic Republic 281807 ➤ Sign Up
Germany 10399005 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
Colorcon
Covington
AstraZeneca
Johnson and Johnson
McKinsey
US Army
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot